Canada Life’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $220K | Hold |
7,024
| – | – | ﹤0.01% | 1697 |
|
2025
Q1 | $236K | Sell |
7,024
-8,887
| -56% | -$299K | ﹤0.01% | 1709 |
|
2024
Q4 | $623K | Hold |
15,911
| – | – | ﹤0.01% | 1595 |
|
2024
Q3 | $628K | Hold |
15,911
| – | – | ﹤0.01% | 1632 |
|
2024
Q2 | $621K | Buy |
15,911
+5,879
| +59% | +$229K | ﹤0.01% | 1628 |
|
2024
Q1 | $432K | Buy |
10,032
+4,691
| +88% | +$202K | ﹤0.01% | 1718 |
|
2023
Q4 | $244K | Buy |
5,341
+848
| +19% | +$38.7K | ﹤0.01% | 1809 |
|
2023
Q3 | $153K | Buy |
4,493
+2,800
| +165% | +$95.3K | ﹤0.01% | 1895 |
|
2023
Q2 | $66K | Sell |
1,693
-699
| -29% | -$27.3K | ﹤0.01% | 1979 |
|
2023
Q1 | $86K | Hold |
2,392
| – | – | ﹤0.01% | 1996 |
|
2022
Q4 | $95K | Hold |
2,392
| – | – | ﹤0.01% | 1996 |
|
2022
Q3 | $86K | Buy |
2,392
+535
| +29% | +$19.2K | ﹤0.01% | 2015 |
|
2022
Q2 | $56K | Hold |
1,857
| – | – | ﹤0.01% | 2040 |
|
2022
Q1 | $60K | Hold |
1,857
| – | – | ﹤0.01% | 2114 |
|
2021
Q4 | $58K | Buy |
1,857
+753
| +68% | +$23.5K | ﹤0.01% | 2138 |
|
2021
Q3 | $17K | Hold |
1,104
| – | – | ﹤0.01% | 2469 |
|
2021
Q2 | $21K | Sell |
1,104
-1,313
| -54% | -$25K | ﹤0.01% | 2479 |
|
2021
Q1 | $43K | Hold |
2,417
| – | – | ﹤0.01% | 2337 |
|
2020
Q4 | $37K | Hold |
2,417
| – | – | ﹤0.01% | 2386 |
|
2020
Q3 | $27K | Hold |
2,417
| – | – | ﹤0.01% | 2365 |
|
2020
Q2 | $30K | Buy |
+2,417
| New | +$30K | ﹤0.01% | 2402 |
|